Concepedia

Author

Toon Van Gorp

KU LeuvenORCID

Also Known As

Gorp, Toon Van, Ignace Vergote, Jean-Francois Baurain, Liv Cecilie V. Thomsen, Maaike A. van der Aa, T Gorp, T Van Gorp, T van Gorp, T. VAN GORP, T. Van Gorp

449

Publications

8.2K

Citations

44

H-Index

68

Concepts

All Affiliations

KU LeuvenMaastricht University Medical CentreMaastricht UniversityAgostino Gemelli University PolyclinicCharité - Universitätsmedizin Berlin
TV

About

Toon Van Gorp is an author at KU Leuven specializing in medicine, obstetrics, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

23

43

1.7K

2

Health Sciences

9

9

338

3

Public Health

5

5

128

4

Anatomy

2

2

70

5

Engineering

1

1

16

Toon Van Gorp

×

112

Publications

5.6K

Citations

38

H-Index

YearCitations

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

Toon Van Gorp, Isabelle Cadron, Evelyn Despierre,

British Journal of Cancer

2011

348

A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)

Bradley J. Monk, Christine Parkinson, Myong Cheol Lim,

Journal of Clinical Oncology

2022

346

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study

Ursula A. Matulonis, Domenica Lorusso, Ana Oaknin,

Journal of Clinical Oncology

2023

321

Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer

Kathleen N. Moore, Antoine Angelergues, Gottfried E. Konecny,

New England Journal of Medicine

2023

316

Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients

Iris J.G. Rutten, David P.J. van Dijk, Roy F.P.M. Kruitwagen,

Journal of Cachexia Sarcopenia and Muscle

2016

198

High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification

Siel Olbrecht, Pieter Busschaert, Adriaan Vanderstichele,

Genome Medicine

2021

180

Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer

Iris J.G. Rutten, Jorne Ubachs, Roy F.P.M. Kruitwagen,

Journal of Cachexia Sarcopenia and Muscle

2017

176

The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma — Analysis of patient data in the prospective OVCAD study

Gerda Hofstetter, Nicole Concin, Radoslav Chekerov,

Gynecologic Oncology

2013

133

Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial

Marianne J. Rutten, Hannah S. van Meurs, Roelien van de Vrie,

Journal of Clinical Oncology

2017

133

Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses

Toon Van Gorp, Joan Veldman, Ben Van Calster,

European Journal of Cancer

2012

126

Page 1